Home4K4 • FRA
add
Stayble Therapeutics AB
Previous close
€0.022
Day range
€0.018 - €0.018
Year range
€0.013 - €0.053
Market cap
13.58M SEK
Avg Volume
34.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
MarketWatch
6 hours ago
S&P 500 hits record high on Christmas Eve for first time in more than a decade
0.32%
0.60%
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.48M | -37.11% |
Net income | -1.48M | 36.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.80M | — |
Total assets | 9.90M | — |
Total liabilities | 1.44M | — |
Total equity | 8.46M | — |
Shares outstanding | 64.36M | — |
Price to book | 0.17 | — |
Return on assets | -33.58% | — |
Return on capital | -36.90% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.48M | 36.53% |
Cash from operations | -1.85M | 58.60% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.85M | 58.62% |
Free cash flow | -1.29M | — |
About
Founded
2015
Website
Employees
2
